Expanding the market, not just redistributing it The greatest opportunity for oral GLP-1s may not be taking share from injectable products, but expanding the overall market
Prognostic Impact of Genetic Variants of CYP19A1 and UGT2B17 in a Randomized Trial for Endocrine-Responsive Postmenopausal Breast Cancer. The Pharmacogenomics Journal, Apr
Emerging preclinical research suggests that GLP-1 receptor agonists may directly inhibit the proliferation of neoplastic cells, promote programmed cell death (apoptosis), and reduce metastatic potential through the regulation of matrix metalloproteinases and their inhibitors
A full medical evaluation at a trusted medical spa or by an obesity medicine doctor ensures safe use
Smoke, alcohol and drug addiction and female fertility
We recommend using it only once a day, especially if there are other active ingredients in your routine